29.58USD-1.45%Mkt Cap: 1.35B USDP/E: —Last update: 2026-06-01
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.35B USD
Enterprise Value1.04B USD
Revenue (TTM)72.25M USD
Gross Profit72.25M USD
Net Income (TTM)-48.88M USD
Revenue/Share1.625 USD
Last Price29.58 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees130
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-11.36
PEG—
EV/EBITDA-15.58
EV/Revenue14.35
P/S18.84
P/B3.54
EPS (TTM)-0.80
EPS (Forward)-2.66
52W Range
9.11087% of range32.63
52W High32.63 USD
52W Low9.110 USD
Profitability
Gross Margin100.00%
Oper. Margin-50.14%
EBITDA Margin-92.12%
Profit Margin-106.37%
ROE-12.80%
ROA-8.20%
Growth
Revenue Growth12011.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF110.19M USD
CapEx (TTM)518.00K USD
FCF Margin33.24%
FCF Yield1.78%
Net Debt-324.31M USD
Net Debt/EBITDA4.87
Balance Sheet
Debt/Equity0.06
Current Ratio4.71
Quick Ratio4.63
Book Value/Sh8.524 USD
Cash/Share7.707 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)44.25 USD
Target Range35.00 USD – 60.00 USD
# Analysts8
Ownership
Shares Out.45.08M
Float23.12M
Insiders3.09%
Institutions102.61%
Short Interest
Short Ratio6.4d
Short % Float10.47%
Short % Out.5.30%
Shares Short2.39M
Short (prev mo.)2.46M
Technical
SMA 5025.38 (+16.6%)
SMA 20023.31 (+26.9%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)311.13K
Avg Vol (10d)336.50K
Technical Indicators
RSI (14)64.3
MACD1.3888
MACD Signal0.8838
MACD Hist.+0.5050
BB Upper31.47 USD
BB Middle26.57 USD
BB Lower21.66 USD
BB Width36.93%
ATR (14)1.766 USD
Vol Ratio (20d)0.43x